Drug induced pseudolymphoma secondary to ethosuximide [6]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 11, 2005, Pages 1610-

  Masruha, Marcelo Rodrigues ^a   Marques, C M ^a   Vilanova, L C P ^a   De Seixas Alves, M T ^a   Peres, M F P ^b   Rodrigues, M G ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETHOSUXIMIDE;

ABSENCE; AXILLA; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; DRUG FEVER; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; INGUINAL REGION; LETTER; LEUKOPENIA; MALE; PRIORITY JOURNAL; PSEUDOLYMPHOMA; SCHOOL CHILD; SIDE EFFECT; THROMBOCYTOPENIA; TUMOR BIOPSY; TUMOR DIAGNOSIS; TUMOR REGRESSION; TUMOR VOLUME; WEIGHT REDUCTION;

ANTICONVULSANTS; BIOPSY; CHILD; ETHOSUXIMIDE; HUMANS; HYPERPLASIA; LYMPH NODES; MALE; PSEUDOLYMPHOMA;

EID: 27444438164     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.064923     Document Type: Letter

References (5)

1. McCabe PH. New anti-epileptic drugs for the 21st century. Expert Opin Pharmacother 2000;1:633-74.
2. Cooper R, Burrows RGR. Treatment of epilepsy with sodium diphenylhydantoinate. Lancet, 1940;i, 490-2.
3. Pathak P, McLachlan RS. Drug-induced pseudolymphoma secondary to lamotrigine. Neurology 1998;50:1509-10.
4. Jeng YM, Tien HF, Su IF. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques. Epilepsia 1990;37:104-7.
5. Ojinnaka NC, Iloeje SO. Ethosuximide induced lymphadenopathy - a case report. Cent Afr J Med 2001;47:18-19.